Newsroom | 43255 results
Sorted by: Latest
-
National Condom Month: Why Today’s Protection Is About Pleasure, Confidence and Connection, According to Sex & Relationship Expert, Dr. Deb Laino
PHILADELPHIA--(BUSINESS WIRE)--In recognition of National Condom Month, sex and relationship therapist Dr. Deb Laino is encouraging young adults to prioritize safer sex practices - not just for protection, but for the emotional and relational benefits that come with feeling secure and aligned with your partner. As conversations around consent and sexual wellness continue to evolve, Dr. Laino emphasizes that condoms are not just about prevention - they help create a shared understanding of respo...
-
Caidya任命Michael Clay為營運長,推動卓越營運和多區域臨床研發
北卡羅來納州羅利--(BUSINESS WIRE)--(美國商業資訊)-- Caidya是一家全球首屈一指的中型委託研究機構(CRO),專注為創新生物製藥企業加快臨床研發進程。公司今日宣布任命Michael Clay為營運長(COO)。Clay將負責Caidya的全球營運交付、客戶合作模式和執行策略,進一步強化公司為美國、歐洲和亞太地區創新生物製藥試驗委託者提供服務的能力。 Clay在全球專案交付和研究中心合作策略方面擁有卓越的過往業績。他曾領導遍及60多個國家的大型全球計畫,打造了以營運嚴謹性和贏得試驗委託者信任而著稱的高績效交付團隊。 值得一提的是,Clay在亞太地區擁有豐富的領導經驗——在該地區,速度、監管細則和與研究中心的密切合作對成功至關重要。他親自參與研究中心合作和區域執行的方式,與Caidya獨特的全球布局和在中國的強大影響力高度契合——中國對於創新生物科技研發和病患可及性而言正日益成為至關重要的地區。 Clay最近擔任Fortrea全球專案交付資深副總裁,負責超過500項全球臨床試驗。其職業生涯中還曾在其他全球委託研究機構和研究中心管理機構擔任營運長和高階營運職務。他在...
-
Caidya任命Michael Clay为首席运营官,推动卓越运营和多区域临床研发
北卡罗来纳州罗利--(BUSINESS WIRE)--(美国商业资讯)-- Caidya是一家全球领先的中型合同研究组织(CRO),专注为创新生物制药企业加速临床研发进程。公司今日宣布任命Michael Clay为首席运营官(COO)。Clay将负责Caidya的全球运营交付、客户合作模式和执行策略,进一步强化公司为美国、欧洲和亚太地区创新生物制药申办方提供服务的能力。 Clay在全球项目交付和研究中心合作策略方面拥有卓越的过往业绩。他曾领导遍及60多个国家的大型全球项目,打造了以运营严谨性和赢得申办方信任而著称的高绩效交付团队。 值得一提的是,Clay在亚太地区拥有丰富的领导经验——在该地区,速度、监管细节和与研究中心的紧密协作对成功至关重要。他亲自参与研究中心合作和区域执行的方式,与Caidya独特的全球布局和在中国的强大影响力高度契合——中国对于创新生物技术研发和患者可及性而言正日益成为至关重要的地区。 Clay最近担任Fortrea全球项目交付高级副总裁,负责超过500项全球临床试验。其职业生涯中还曾在其他全球合同研究组织和研究中心管理机构担任首席运营官和高级运营职务。他在整合...
-
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2025
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, 2025. Financial Results Revenue Consolidated revenues for fiscal 2025 were $31.6 million compared to $32.0 million for fiscal 2024. The revenues for fiscal 2025 consisted of $31.4 million in processing and storage fee revenue, $54,000 in product revenue...
-
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the award of inducement grants. On February 24, 2026, as an inducement material to acceptance of employment with CareDx, 35 new employees were awarded restricted stock units (RSUs) for an agg...
-
Free Live Webinar Wednesday -- Behind The Olympics with America’s Most Decorated Cross Country Skier Jessie Diggins
SAINT PAUL, Minn.--(BUSINESS WIRE)--The Emily Program announced a free public webinar, Up Close with Jessie Diggins, who speaks openly about her recovery from an eating disorder....
-
OSSTEC Appoints Dr. Nick Pachuda to Board and Establishes US Operations Ahead of US Market Entry
LONDON--(BUSINESS WIRE)--OSSTEC Appoints Dr. Nick Pachuda to Board and Establishes US Operations Ahead of US Market Entry...
-
Sun Nuclear celebra el QADS 2026, un encuentro que combina experiencia clínica e innovación para garantizar la calidad en radioterapia
MELBOURNE, Fla.--(BUSINESS WIRE)--Sun Nuclear, empresa de Mirion Medical, ha inaugurado hoy el QA & Dosimetry Symposium (QADS), que se celebra durante los próximos dos días en Roma (Italia). En su decimoquinta edición, el encuentro reúne a más de 230 físicos clínicos y profesionales de la medicina radioterapéutica procedentes de cerca de 40 países. Los asistentes, provenientes de entornos clínicos diversos, obtendrán créditos de formación continua mientras comparten experiencias prácticas,...
-
L'evento Sun Nuclear QADS 2026 unisce le conoscenze cliniche e le ultime novità per il progresso della garanzia di qualità nella radioterapia
MELBOURNE, Fla.--(BUSINESS WIRE)--Sun Nuclear, un'azienda Mirion Medical, oggi ha aperto il QA & Dosimetry Symposium (QADS), che si svolgerà nei prossimi due giorni a Roma. La 15esima edizione riunisce più di 230 fisici clinici e professionisti della medicina radiologica provenienti da circa 40 Paesi. I partecipanti da diversi ambienti clinici otterranno crediti di formazione continua condividendo informazioni pratiche, approcci emergenti ed esperienze concrete che creano il futuro della qu...
-
Die Veranstaltung Sun Nuclear QADS 2026 vereint klinische Erkenntnisse und neue Innovationen zur Weiterentwicklung der Qualitätssicherung in der Strahlentherapie
MELBOURNE, Fla.--(BUSINESS WIRE)--Sun Nuclear, ein Unternehmen von Mirion Medical, eröffnete heute das QA & Dosimetry Symposium (QADS), das in den kommenden zwei Tagen in Rom, Italien, stattfindet. Die 15. Austragung bringt mehr als 230 Medizinphysiker und Fachleute der Strahlenmedizin aus nahezu 40 Ländern zusammen. Teilnehmer aus unterschiedlichen klinischen Umfeldern erwerben Fortbildungspunkte und tauschen zugleich praxisnahe Erkenntnisse, neue Ansätze sowie Erfahrungen aus dem klinisch...